Healthcare provider profile · identity verified

Paul S. Gotlieb, M.D.

Internal Medicine · EDINA, MN · NPI 1578569042

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	934	281
Amlodipine Besylate	Amlodipine Besylate	792	244
Losartan Potassium	Losartan Potassium	449	131
Lisinopril	Lisinopril	417	116
Metoprolol Succinate	Metoprolol Succinate	416	124
Simvastatin	Simvastatin	387	111
Rosuvastatin Calcium	Rosuvastatin Calcium	382	121
Levothyroxine Sodium	Levothyroxine Sodium	298	86
Omeprazole	Omeprazole	290	88
Hydrochlorothiazide	Hydrochlorothiazide	287	86
Tamsulosin Hcl	Tamsulosin Hcl	205	72
Pantoprazole Sodium	Pantoprazole Sodium	172	56
Eliquis	Apixaban	168	56
Gabapentin	Gabapentin	160	44
Escitalopram Oxalate	Escitalopram Oxalate	140	44
Sertraline Hcl	Sertraline Hcl	140	44
Allopurinol	Allopurinol	137	42
Trazodone Hcl	Trazodone Hcl	137	36
Ozempic	Semaglutide	134	22
Alendronate Sodium	Alendronate Sodium	131	47
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	115	31
Metformin Hcl	Metformin Hcl	113	33
Metformin Hcl Er	Metformin Hcl	109	34
Valsartan	Valsartan	107	31
Citalopram Hbr	Citalopram Hydrobromide	104	28
Atenolol	Atenolol	102	28
Finasteride	Finasteride	102	30
Lorazepam	Lorazepam	100	33
Warfarin Sodium	Warfarin Sodium	95	23
Metoprolol Tartrate	Metoprolol Tartrate	94	29
Furosemide	Furosemide	92	30
Famotidine	Famotidine	91	30
Carvedilol	Carvedilol	88	30
Xarelto	Rivaroxaban	88	28
Clopidogrel	Clopidogrel Bisulfate	80	20
Spironolactone	Spironolactone	80	24
Glimepiride	Glimepiride	77	24
Ezetimibe	Ezetimibe	74	25
Jardiance	Empagliflozin	73	25
Fluticasone Propionate	Fluticasone Propionate	64	23
Mounjaro	Tirzepatide	62	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	61	20
Irbesartan	Irbesartan	57	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	16
Duloxetine Hcl	Duloxetine Hcl	53	15
Celecoxib	Celecoxib	49	17
Potassium Chloride	Potassium Chloride	48	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	48	13
Fluoxetine Hcl	Fluoxetine Hcl	47	14
Pravastatin Sodium	Pravastatin Sodium	47	14
Chlorthalidone	Chlorthalidone	46	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	46	15
Valacyclovir	Valacyclovir Hcl	46	18
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	46	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	12
Mirtazapine	Mirtazapine	44	11
Tramadol Hcl	Tramadol Hcl	42	12
Paroxetine Hcl	Paroxetine Hcl	41	14
Synthroid	Levothyroxine Sodium	41	suppressed
Bupropion Xl	Bupropion Hcl	40	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	13
Ipratropium Bromide	Ipratropium Bromide	40	17
Montelukast Sodium	Montelukast Sodium	39	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	36	11
Myrbetriq	Mirabegron	36	11
Alfuzosin Hcl Er	Alfuzosin Hcl	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	11
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Amoxicillin	Amoxicillin	29	19
Prednisone	Prednisone	28	16
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	23	14
Clonazepam	Clonazepam	23	suppressed
Estradiol	Estradiol	23	11
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Nitroglycerin	Nitroglycerin	23	12
Torsemide	Torsemide	23	11
Advair Hfa	Fluticasone Propion/Salmeterol	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Diazepam	Diazepam	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	14
Acyclovir	Acyclovir	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Indapamide	Indapamide	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Ramipril	Ramipril	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Baclofen	Baclofen	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Lactulose	Lactulose	13	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error